Literature DB >> 31503051

Stressful Life Events Moderate the Relationship Between Changes in Symptom Severity and Health-related Quality of Life in Patients With Irritable Bowel Syndrome.

Yuanjun Dong1, David Baumeister, Sabrina Berens, Wolfgang Eich, Jonas Tesarz.   

Abstract

OBJECTIVES: The relationship between changes in symptom severity and health-related quality of life (HRQOL), which may be impacted by stressful life events, in irritable bowel syndrome (IBS), is unclear. Therefore, we investigated the relationship between changes in symptom severity and HRQOL and examined the moderating role of stressful life events in patients with IBS.
METHODS: This study is part of a cohort follow-up study on psychological factors in patients with IBS in tertiary care, and it included 158 patients. In addition to symptom severity and HRQOL, stressful life events were assessed by the Social Readjustment Rating Scale (SRRS). The relationship between symptom severity and HRQOL and the moderating role of stressful life events (in the 12 mo before the follow-up assessment) were analyzed.
RESULTS: The majority of participants had moderate levels of stressful life events (41.8%), followed by those who had mild levels (39.2%) and severe levels (19.0%) of stressful life events. Symptom severity could predict HRQOL, and the relationship between symptom severity and HRQOL was affected by the level of stressful life events. Compared with mild levels of stressful life events, a severe level of stressful life events significantly affected the relationship between changes in symptom severity and HRQOL (Z=-3.048, P<0.01). A similar result was found when comparing moderate and severe levels of stressful life events (Z=-1.810, P<0.10).
CONCLUSIONS: The study demonstrated that symptom severity predicted HRQOL during the progression of IBS and that stressful life events moderated the impact of symptom severity on HRQOL. The more stressful life events an IBS patient experiences, the less predictable the relationship is between changes in symptom severity and HRQOL.

Entities:  

Mesh:

Year:  2020        PMID: 31503051     DOI: 10.1097/MCG.0000000000001261

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  3 in total

1.  Serotonin type 3 receptor subunit gene polymorphisms associated with psychosomatic symptoms in irritable bowel syndrome: A multicenter retrospective study.

Authors:  Sabrina Berens; Yuanjun Dong; Nikola Fritz; Jutta Walstab; Mauro D'Amato; Tenghao Zheng; Verena Wahl; Felix Boekstegers; Justo Lorenzo Bermejo; Cristina Martinez; Stefanie Schmitteckert; Egbert Clevers; Felicitas Engel; Annika Gauss; Wolfgang Herzog; Robin Spiller; Miriam Goebel-Stengel; Hubert Mönnikes; Viola Andresen; Frieling Thomas; Jutta Keller; Christian Pehl; Christoph Stein-Thöringer; Gerard Clarke; Timothy G Dinan; Eamonn M Quigley; Gregory Sayuk; Magnus Simrén; Jonas Tesarz; Gudrun Rappold; Lukas van Oudenhove; Rainer Schaefert; Beate Niesler
Journal:  World J Gastroenterol       Date:  2022-06-07       Impact factor: 5.374

2.  Probiotic Mixture Containing Lactobacillus helveticus, Bifidobacterium longum and Lactiplantibacillus plantarum Affects Brain Responses to an Arithmetic Stress Task in Healthy Subjects: A Randomised Clinical Trial and Proof-of-Concept Study.

Authors:  Hanna M T Edebol Carlman; Julia Rode; Julia König; Dirk Repsilber; Ashley N Hutchinson; Per Thunberg; Jonas Persson; Andrey Kiselev; Jens C Pruessner; Robert J Brummer
Journal:  Nutrients       Date:  2022-03-22       Impact factor: 5.717

3.  Stressful life events and social capital during the early phase of COVID-19 in the U.S.

Authors:  Cindy Ogolla Jean-Baptiste; R Patti Herring; W Lawrence Beeson; Hildemar Dos Santos; Jim E Banta
Journal:  Soc Sci Humanit Open       Date:  2020-08-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.